Anti-TRBC1 CAR-T Cell Therapy in Patients With TRBC1 Positive T Cell Malignancies

Clinical trial NCT04828174 · SUSPENDED

Trial details

NCT number: NCT04828174
Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Status: SUSPENDED
Phase: Phase 1
Study type: INTERVENTIONAL

Peripheral T Cell Lymphoma Angioimmunoblastic T-cell Lymphoma Anaplastic Lymphoma Acute T Cell Leukemia T-lymphoblastic Lymphoma

Start date: 2021-03-31
Primary completion: 2023-11-26
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.